{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:26:56Z","timestamp":1784820416246,"version":"3.55.0"},"reference-count":122,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Sjogren\u2019s syndrome (SS) is an autoimmune disease that manifests primarily in salivary and lacrimal glands leading to dry mouth and eyes. Unfortunately, there is no cure for SS due to its complex etiopathogenesis. Mesenchymal stem cells (MSCs) were successfully tested for SS, but some risks and limitations remained for their clinical use. This study combined cell- and biologic-based therapies by utilizing the MSCs extract (MSCsE) to treat SS-like disease in NOD mice. We found that MSCsE and MSCs therapies were successful and comparable in preserving salivary and lacrimal glands function in NOD mice when compared to control group. Cells positive for AQP5, AQP4, \u03b1-SMA, CK5, and c-Kit were preserved. Gene expression of AQP5, EGF, FGF2, BMP7, LYZ1 and IL-10 were upregulated, and downregulated for TNF-\u03b1, TGF-\u03b21, MMP2, CASP3, and IL-1\u03b2. The proliferation rate of the glands and serum levels of EGF were also higher. Cornea integrity and epithelial thickness were maintained due to tear flow rate preservation. Peripheral tolerance was re-established, as indicated by lower lymphocytic infiltration and anti-SS-A antibodies, less BAFF secretion, higher serum IL-10 levels and FoxP3+ Treg cells, and selective inhibition of B220+ B cells. These promising results opened new venues for a safer and more convenient combined biologic- and cell-based therapy.<\/jats:p>","DOI":"10.3390\/ijms20194750","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T03:06:51Z","timestamp":1569467211000},"page":"4750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren\u2019s Syndrome-Like Disease"],"prefix":"10.3390","volume":"20","author":[{"given":"Ghada","family":"Abughanam","sequence":"first","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-7534","authenticated-orcid":false,"given":"Osama A.","family":"Elkashty","sequence":"additional","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younan","family":"Liu","sequence":"additional","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed O.","family":"Bakkar","sequence":"additional","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-359X","authenticated-orcid":false,"given":"Simon D.","family":"Tran","sequence":"additional","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0049-0172(84)90001-5","article-title":"Primary Sjogren syndrome: Clinical and immunopathologic features","volume":"14","author":"Fox","year":"1984","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.arcmed.2006.08.002","article-title":"Pathophysiology of Sjogren\u2019s syndrome","volume":"37","author":"Escarcega","year":"2006","journal-title":"Arch. Med. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/ard.2004.031021","article-title":"Sjogren\u2019s syndrome: A population based study of prevalence in Greece. The ESORDIG study","volume":"64","author":"Trontzas","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren\u2019s syndrome in north-west Greece, 1982\u20132003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/03009740600759704","article-title":"The prevalence of Sjogren\u2019s syndrome in adult women","volume":"35","author":"Kabasakal","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1742-1241.2008.01749.x","article-title":"Prevalence of primary Sjogren\u2019s syndrome in Turkey: A population-based epidemiological study","volume":"63","author":"Birlik","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Anagnostopoulos, I., Zinzaras, E., Alexiou, I., Papathanasiou, A.A., Davas, E., Koutroumpas, A., Barouta, G., and Sakkas, L.I. (2010). The prevalence of rheumatic diseases in central Greece: A population survey. BMC Musculoskelet. Disord., 11.","DOI":"10.1186\/1471-2474-11-98"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03009742.2010.536164","article-title":"The point prevalence of clinically relevant primary Sjogren\u2019s syndrome in two Norwegian counties","volume":"40","author":"Goransson","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sjogren\u2019s syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s40496-016-0112-0","article-title":"Epidemiology of Sjogren\u2019s Syndrome-from an Oral Perspective","volume":"3","author":"Bolstad","year":"2016","journal-title":"Curr. Oral Health Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1601-0825.2006.01292.x","article-title":"Sjogren\u2019s syndrome: Why autoimmune epithelitis?","volume":"12","author":"Mitsias","year":"2006","journal-title":"Oral Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sjogren\u2019s syndrome: Clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11882-013-0403-7","article-title":"Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca","volume":"14","author":"Liu","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_16","first-page":"3","article-title":"Sjogren\u2019s syndrome: Mechanisms of pathogenesis involve interaction of immune and neurosecretory systems","volume":"116","author":"Fox","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-014-3072-5","article-title":"Sjogren\u2019s syndrome: Still not fully understood disease","volume":"35","author":"Maslinska","year":"2015","journal-title":"Rheumatol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0030-4220(86)90313-0","article-title":"Sjogren\u2019s syndrome: Clinical and laboratory features, immunopathogenesis, and management","volume":"62","author":"Scully","year":"1986","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0722.2004.00183.x","article-title":"Sjogren\u2019s syndrome","volume":"113","author":"Delaleu","year":"2005","journal-title":"Eur. J. Oral Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0950-3579(05)80254-7","article-title":"Sjogren\u2019s syndrome","volume":"9","author":"Manthorpe","year":"1995","journal-title":"Bailliere\u2019s Clin. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sjogren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_22","first-page":"365","article-title":"Sjogren\u2019s Syndrome: Oral Manifestations and Treatment, a Dental Perspective","volume":"89","author":"Cartee","year":"2015","journal-title":"J. Dent. Hyg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment Guidelines for Rheumatologic Manifestations of Sjogren\u2019s Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coms.2013.09.009","article-title":"Management of extraglandular manifestations of primary Sjogren\u2019s syndrome","volume":"26","author":"Wu","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coms.2013.09.010","article-title":"Management of xerostomia and other complications of Sjogren\u2019s syndrome","volume":"26","author":"Pinto","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_26","unstructured":"Fernandez-Martinez, G., Zamora-Legoff, V., and Hernandez Molina, G. (2018). Oral health-related quality of life in primary Sjogren\u2019s syndrome. Reumatol. Clin."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ngo, D.Y.J., Thomson, W.M., Nolan, A., and Ferguson, S. (2016). The lived experience of Sjogren\u2019s Syndrome. BMC Oral Health, 16.","DOI":"10.1186\/s12903-016-0165-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e000443","DOI":"10.1136\/rmdopen-2017-000443","article-title":"Patient burden of Sjogren\u2019s: A comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity","volume":"3","author":"Hammitt","year":"2017","journal-title":"RMD Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mammana, S., Gugliandolo, A., Cavalli, E., Diomede, F., Iori, R., Zappacosta, R., Bramanti, P., Conti, P., Fontana, A., and Pizzicannella, J. (2019). Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury. J. Tissue Eng. Regen. Med.","DOI":"10.1002\/term.2857"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/stem.2651","article-title":"Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases","volume":"35","author":"Volkman","year":"2017","journal-title":"Stem Cells"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/2231-0746.147130","article-title":"Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells","volume":"4","author":"Manimaran","year":"2014","journal-title":"Ann. Maxillofac. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Freitag, J., Wickham, J., Shah, K., and Tenen, A. (2019). Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis. BMJ Case Rep., 12.","DOI":"10.1136\/bcr-2018-227865"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/cam.20875","article-title":"Mesenchymal stem cells in tumor development: Emerging roles and concepts","volume":"6","author":"Cuiffo","year":"2012","journal-title":"Cell Adhes. Migr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/icb.2012.64","article-title":"Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells","volume":"91","author":"Jacobs","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J. Inflamm."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rota, C., Morigi, M., and Imberti, B. (2019). Stem Cell Therapies in Kidney Diseases: Progress and Challenges. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112790"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13770-019-00178-y","article-title":"Stem Cell-Based Therapies for Liver Diseases: An Overview and Update","volume":"16","author":"Wang","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Barbado, J., Tabera, S., Sanchez, A., and Garcia-Sancho, J. (2018). Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus.","DOI":"10.1177\/0961203318804922"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2018.03.041","article-title":"Current advanced therapy cell-based medicinal products for type-1-diabetes treatment","volume":"543","author":"Ciriza","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10787-017-0404-6","article-title":"Mesenchymal stromal cells modulate gut inflammation in experimental colitis","volume":"26","author":"Castoldi","year":"2018","journal-title":"Inflammopharmacology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Genc, B., Bozan, H.R., Genc, S., and Genc, K. (2018). Stem Cell Therapy for Multiple Sclerosis. Adv. Exp. Med. Biol.","DOI":"10.1007\/5584_2018_247"},{"key":"ref_45","first-page":"712","article-title":"Experimental research on mesenchymal stem cells (MSCs) therapy for autoimmune uveitis","volume":"54","author":"Lu","year":"2018","journal-title":"Chin. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15283\/ijsc17052","article-title":"Therapeutic Efficacy of Mesenchymal Stem Cells and Mesenchymal Stem Cells-derived Neural Progenitors in Experimental Autoimmune Encephalomyelitis","volume":"11","author":"Nasri","year":"2018","journal-title":"Int. J. Stem Cells"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13287-018-0941-y","article-title":"Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2","volume":"9","author":"Sevim","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_48","first-page":"152","article-title":"The curative effects of bone mesenchymal stem cells transplanted into rats with Sjogren\u2019s syndrome","volume":"20","author":"Yang","year":"2011","journal-title":"Shanghai J. Stomatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Khalili, S., Liu, Y., Kornete, M., Roescher, N., Kodama, S., Peterson, A., Piccirillo, C.A., and Tran, S.D. (2012). Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjogren\u2019s-like disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038615"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3134543","DOI":"10.1155\/2017\/3134543","article-title":"Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjogren\u2019s Syndrome","volume":"2017","author":"Aluri","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4939-6756-8_3","article-title":"Compact Bone-Derived Multipotent Mesenchymal Stromal Cells (MSCs) for the Treatment of Sjogren\u2019s-like Disease in NOD Mice","volume":"1553","author":"Elghanam","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13287-017-0593-3","article-title":"Mesenchymal stem cells for treating autoimmune dacryoadenitis","volume":"8","author":"Lu","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3892\/etm.2017.4313","article-title":"Effect of mesenchymal stem cells on Sjogren-like mice and the microRNA expression profiles of splenic CD4+ T cells","volume":"13","author":"Ruan","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/scd.2017.0045","article-title":"Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjogren\u2019s Syndrome: A Preliminary Study","volume":"26","author":"Wang","year":"2017","journal-title":"Stem Cells Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal Stem Cell Transplantation Reverses Multi-Organ Dysfunction in Systemic Lupus Erythematosus Mice and Humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fphys.2019.00512","article-title":"Engineered Extracellular Vesicles From Human Periodontal-Ligament Stem Cells Increase VEGF\/VEGFR2 Expression During Bone Regeneration","volume":"10","author":"Pizzicannella","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ghiroldi, A., Piccoli, M., Cirillo, F., Monasky, M.M., Ciconte, G., Pappone, C., and Anastasia, L. (2018). Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103194"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcyt.2018.01.009","article-title":"MSCs\u2014Cells with many sides","volume":"20","author":"Davies","year":"2018","journal-title":"Cytotherapy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.coi.2010.10.012","article-title":"Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?","volume":"22","author":"Uccelli","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cagliani, J., Grande, D., Molmenti, E.P., Miller, E.J., and Rilo, H.L.R. (2017). Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications. J. Stem Cell Regen. Biol., 3.","DOI":"10.15436\/2471-0598.17.022"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12272-012-0202-z","article-title":"Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications","volume":"35","author":"Yi","year":"2012","journal-title":"Arch. Pharmacal Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/rheumatology\/keu292","article-title":"In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjogren\u2019s syndrome","volume":"54","author":"Alunno","year":"2015","journal-title":"Rheumatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/1756-185X.13182","article-title":"Renal involvement in primary Sjogren\u2019s syndrome: A retrospective study of 103 biopsy-proven cases from a single center in China","volume":"21","author":"Yang","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Magni","year":"2002","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2008.52","article-title":"Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice","volume":"5","author":"Zhou","year":"2008","journal-title":"Cell. Mol. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.1007\/s13277-016-5187-7","article-title":"Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells","volume":"37","author":"Norozi","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/sci.2017.07.03","article-title":"Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence","volume":"4","author":"Grockowiak","year":"2017","journal-title":"Stem Cell Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/srep16017","article-title":"Identification of the active components in Bone Marrow Soup: A mitigator against irradiation-injury to salivary glands","volume":"5","author":"Fang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Arellano-Garcia, M.E., Misuno, K., Tran, S.D., and Hu, S. (2014). Interferon-gamma induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102878"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/mt.2009.85","article-title":"Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy","volume":"17","author":"Yeghiazarians","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jcp.20494","article-title":"Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells","volume":"206","author":"Bullwinkel","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1167\/iovs.06-1129","article-title":"The cornea in Sjogren\u2019s syndrome: An in vivo confocal study","volume":"48","author":"Villani","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"125sr121","DOI":"10.1126\/scitranslmed.3003504","article-title":"Treating human autoimmunity: Current practice and future prospects","volume":"4","author":"Rosenblum","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcyt.2013.10.006","article-title":"Treatment for salivary gland hypofunction at both initial and advanced stages of Sjogren-like disease: A comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period","volume":"16","author":"Khalili","year":"2014","journal-title":"Cytotherapy"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Misuno, K., Tran, S.D., Khalili, S., Huang, J., Liu, Y., and Hu, S. (2014). Quantitative analysis of protein and gene expression in salivary glands of Sjogren\u2019s-like disease NOD mice treated by bone marrow soup. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087158"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.transproceed.2012.05.091","article-title":"Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy","volume":"45","author":"Gala","year":"2013","journal-title":"Transplant. Proc."},{"key":"ref_79","first-page":"67","article-title":"Comparative evaluation of the treatment of Sjogren\u2019s syndrome with anti-rheumatic preparations","volume":"60","author":"Simonova","year":"1988","journal-title":"Ter. Arkhiv"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"a015560","DOI":"10.1101\/cshperspect.a015560","article-title":"Mesenchymal stromal cells in transplantation rejection and tolerance","volume":"3","author":"English","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/odi.12728","article-title":"Lyophilized bone marrow cell extract functionally restores irradiation-injured salivary glands","volume":"24","author":"Su","year":"2018","journal-title":"Oral Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren\u2019s syndrome: An old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/art.30474","article-title":"Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases","volume":"63","author":"MacDonald","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Soyfoo, M.S., Chivasso, C., Perret, J., and Delporte, C. (2018). Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjogren\u2019s Syndrome. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113392"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Delporte, C. (2009). Aquaporins in secretory glands and their role in Sjogren\u2019s syndrome. Handb. Exp. Pharmacol., 185\u2013201.","DOI":"10.1007\/978-3-540-79885-9_9"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-94-024-1057-0_4","article-title":"Aquaporins and Gland Secretion","volume":"969","author":"Delporte","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/02713680802262819","article-title":"Altered distribution of aquaporin 5 and its C-terminal binding protein in the lacrimal glands of a mouse model for Sjogren\u2019s syndrome","volume":"33","author":"Ohashi","year":"2008","journal-title":"Curr. Eye Res."},{"key":"ref_90","first-page":"2432","article-title":"Leakage of aquaporin 5 in the tear of dacryoadenitis mice","volume":"41","author":"Hirai","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9394(03)00203-4","article-title":"Abnormal protein profiles in tears with dry eye syndrome","volume":"136","author":"Ohashi","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1601-0825.2010.01783.x","article-title":"Salivary gland progenitor cell biology provides a rationale for therapeutic salivary gland regeneration","volume":"17","author":"Lombaert","year":"2011","journal-title":"Oral Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.radonc.2013.05.020","article-title":"Salisphere derived c-Kit+ cell transplantation restores tissue homeostasis in irradiated salivary gland","volume":"108","author":"Nanduri","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation","volume":"13","author":"Miettinen","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00417-018-3926-8","article-title":"Establishing and characterizing lacrispheres from human lacrimal gland for potential clinical application","volume":"256","author":"Tiwari","year":"2018","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1177\/002215540305101212","article-title":"Evaluation of Cell Proliferation in Rat Tissues with BrdU, PCNA, Ki-67 (MIB-5) Immunohistochemistry and In Situ Hybridization for Histone mRNA","volume":"51","author":"Muskhelishvili","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"ref_97","first-page":"1826","article-title":"Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands","volume":"37","author":"Aho","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_98","unstructured":"Dartt, D., Bex, P., D\u2019amore, P., Dana, R., Mcloon, L., and Niederkorn, J. (2011). Lacrimal gland overview. Ocular Periphery and Disorders, Elsevier\/Academic Press."},{"key":"ref_99","first-page":"379","article-title":"Corneal melt as the initial presentation of primary Sjogren\u2019s syndrome","volume":"28","author":"Vivino","year":"2001","journal-title":"J. Rheumatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New Treatment Guidelines for Sjogren\u2019s Disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/OPTH.S119343","article-title":"Corneal thickness in dry eyes in an Iraqi population","volume":"11","author":"Ali","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-016-0924-2","article-title":"B-cell and T-cell quantification in minor salivary glands in primary Sjogren\u2019s syndrome: Development and validation of a pixel-based digital procedure","volume":"18","author":"Costa","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.2005.01688.x","article-title":"The BAFF\/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren\u2019s syndrome","volume":"62","author":"Szodoray","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/kev420","article-title":"Exploring BAFF: Its expression, receptors and contribution to the immunopathogenesis of Sjogren\u2019s syndrome","volume":"55","author":"Hompson","year":"2016","journal-title":"Rheumatology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/rheumatology\/kem097","article-title":"Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: The role of BAFF in T cell-dependent B cell pathogenic autoantibody production","volume":"46","author":"Morimoto","year":"2007","journal-title":"Rheumatology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sjogren\u2019s syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/clim.1999.4759","article-title":"Salivary gland cytokine expression in NOD and normal BALB\/c mice","volume":"92","author":"Yamano","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","article-title":"Mechanisms of mesenchymal stem\/stromal cell function","volume":"7","author":"Spees","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1309.031","article-title":"IL-10-producing T regulatory type 1 cells and oral tolerance","volume":"1029","author":"Battaglia","year":"2004","journal-title":"Ann. N. Y. Acad Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2014.10.031","article-title":"Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy","volume":"74","author":"Saxena","year":"2015","journal-title":"Cytokine"},{"key":"ref_116","first-page":"191","article-title":"The molecular basis of IL-10 function: From receptor structure to the onset of signaling","volume":"380","author":"Walter","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4252\/wjsc.v6.i5.552","article-title":"Secretion of immunoregulatory cytokines by mesenchymal stem cells","volume":"6","author":"Kyurkchiev","year":"2014","journal-title":"World J. Stem Cells"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/labinvest.2010.5","article-title":"Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function","volume":"90","author":"Hall","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.diabres.2012.09.034","article-title":"Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action","volume":"98","author":"Park","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5625\/lar.2017.33.2.171","article-title":"Annual tendency of research papers used ICR mice as experimental animals in biomedical research fields","volume":"33","author":"Kim","year":"2017","journal-title":"Lab. Anim. Res."}],"updated-by":[{"DOI":"10.3390\/ijms22020894","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/19\/4750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:07:07Z","timestamp":1754258827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/19\/4750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":122,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["ijms20194750"],"URL":"https:\/\/doi.org\/10.3390\/ijms20194750","relation":{"correction":[{"id-type":"doi","id":"10.3390\/ijms22020894","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]}}}